ImmunityBio, Inc. IBRX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from ImmunityBio, Inc.’s reported figures.
Based on the most recent quarter.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s price / sales?
- ImmunityBio, Inc. (IBRX) reported price / sales of 56.2× in Q1 2026.
- How has ImmunityBio, Inc.'s price / sales changed year-over-year?
- ImmunityBio, Inc.'s price / sales decreased by 31.7% year-over-year, from 82.3× to 56.2×.
- What is the long-term trend for ImmunityBio, Inc.'s price / sales?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s price / sales has grown at a -69.6% compound annual growth rate (CAGR), from 6,600.2× to 17.2×.
- What does price / sales mean?
- How many dollars investors pay for each dollar of the company's annual sales.
- How do you interpret price / sales?
- Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
- How does price / sales compare across companies?
- Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.